Shaping the future of heart health.

IF 12.8 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

Med Pub Date : 2024-09-13 DOI:10.1016/j.medj.2024.08.002

Alice Y Y Cheng, Shuyang Zhang, Stephan von Haehling, Milind Desai

引用次数: 0

Abstract

For World Heart Day on September 24, 2024, the World Heart Federation urges nations to endorse national strategies for enhancing cardiovascular health. While advancements show promise in reducing atherosclerosis, addressing healthcare inequalities and ensuring equitable access to tools remain crucial. This collection of voices touches on the intricate relationship between type 2 diabetes and cardiovascular disease, highlights innovative treatments for rare cardiomyopathies and heart failure, and explores the potentially transformative role of artificial intelligence in cardiovascular medicine, showcasing the dedication and innovation that are shaping the future of heart health.

查看原文本刊更多论文

塑造心脏健康的未来。

在 2024 年 9 月 24 日 "世界心脏日 "之际，世界心脏联盟敦促各国批准加强心血管健康的国家战略。虽然在减少动脉粥样硬化方面取得的进展显示了希望，但解决医疗保健不平等问题和确保公平获取工具仍然至关重要。这组声音探讨了2型糖尿病与心血管疾病之间错综复杂的关系，重点介绍了罕见心肌病和心力衰竭的创新治疗方法，并探讨了人工智能在心血管医学中的潜在变革作用，展示了塑造心脏健康未来的奉献精神和创新精神。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Med MEDICINE, RESEARCH & EXPERIMENTAL-

CiteScore

17.70

自引率

0.60%

发文量

102

期刊介绍： Med is a flagship medical journal published monthly by Cell Press, the global publisher of trusted and authoritative science journals including Cell, Cancer Cell, and Cell Reports Medicine. Our mission is to advance clinical research and practice by providing a communication forum for the publication of clinical trial results, innovative observations from longitudinal cohorts, and pioneering discoveries about disease mechanisms. The journal also encourages thought-leadership discussions among biomedical researchers, physicians, and other health scientists and stakeholders. Our goal is to improve health worldwide sustainably and ethically. Med publishes rigorously vetted original research and cutting-edge review and perspective articles on critical health issues globally and regionally. Our research section covers clinical case reports, first-in-human studies, large-scale clinical trials, population-based studies, as well as translational research work with the potential to change the course of medical research and improve clinical practice.